Nevro announces FDA approval of HFX iQ spinal cord stimulation system to personalise the treatment of chronic pain

12 October 2022 - Next generation Senza HFX iQ is the first and only spinal cord stimulation system that uses ...

Read more →

FDA will begin accepting breakthrough devices for TAP pilot in 2023

11 October 2022 - The US FDA will start accepting products into its total product lifecycle advisory program (TAP) pilot starting ...

Read more →

Desktop Health receives FDA clearance for SmileGuard resin for durable and comfortable orthodontic and dental appliances

6 October 2022 - Dentists and labs can use proprietary SmileGuard resin to 3D print bite splints, night guards, and mouth ...

Read more →

Stryker receives FDA clearance for OptaBlate bone tumour ablation system

20 September 2022 - Stryker's first bone tumour ablation system with patented microinfusion technology offers a reliable solution for people ...

Read more →

XVIVO granted breakthrough device designation from the FDA for the liver assist device

20 September 2022 - XVIVO Perfusion has been granted breakthrough device designation from the US FDA for their liver assist device, ...

Read more →

Opsens announces FDA clearance for the SavvyWire for use in transcatheter aortic valve replacement procedures

15 September 2022 - OpSens today announced that it has received 510(k) regulatory clearance from the US FDA for the SavvyWire, ...

Read more →

Potrero Medical receives FDA breakthrough device designation for Accuryn AKI predict algorithm

13 September 2022 - Potrero Medical announced today that the FDA granted breakthrough device designation for their AKI Predict machine learning ...

Read more →

Ceribell receives FDA breakthrough device designation for delirium indication

8 September 2022 - Breakthrough device designation recognizes Ceribell's point of care EEG as a first of its kind technology ...

Read more →

Boston Scientific receives FDA approval for expanded labelling of Watchman FLX LAAC device for dual anti-platelet therapy as post-procedural medication option

6 September 2022 - Watchman FLX now the only LAAC technology in the United States that allows for either dual anti-platelet ...

Read more →

FDA approves Abbott's new spinal cord stimulation device; provides tailored relief to multiple pain areas and adds more treatment options for evolving pain conditions

23 August 2022 - Abbott's new Proclaim Plus spinal cord stimulation system offers the next generation of stimulation therapy, giving physicians ...

Read more →

Father invents balance treatment device for daughter; makes history with FDA clearance AND breakthrough device designation

18 August 2022 - GyroStim, a multi-axis rotational chair, was invented by a Colorado father in his garage to aid ...

Read more →

The FDA’s ‘breakthrough’ medical devices are finally hitting the market in numbers

11 August 2022 - The Breakthrough Device Program is approaching terminal velocity.  ...

Read more →

NeuroStar advanced therapy for mental health receives FDA clearance for treatment of anxious depression

19 July 2022 - Indication demonstrates NeuroStar TMS safety and efficacy in improving anxiety symptoms in depressed patients. ...

Read more →

Roche's Elecsys Amyloid Plasma Panel granted FDA breakthrough device designation to enable a timely diagnosis of Alzheimer’s disease

19 July 2022 - The Elecsys Amyloid Plasma Panel is intended to be used in conjunction with other clinical information in ...

Read more →

Renuvion cleared by FDA for neck laxity procedures offering patients a minimally invasive option to eliminate sagging neck

18 July 2022 - Exclusive Apyx Medical device delivers state of the art plasma energy to improve appearance of loose ...

Read more →